A detailed history of Tandem Capital Management Corp transactions in Boston Scientific Corp stock. As of the latest transaction made, Tandem Capital Management Corp holds 55,151 shares of BSX stock, worth $4.8 Million. This represents 2.67% of its overall portfolio holdings.

Number of Shares
55,151
Previous 58,351 5.48%
Holding current value
$4.8 Million
Previous $4.89 Million 5.48%
% of portfolio
2.67%
Previous 2.81%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$72.96 - $84.0 $233,471 - $268,800
-3,200 Reduced 5.48%
55,151 $4.62 Million
Q3 2024

Oct 23, 2024

BUY
$72.96 - $84.0 $35,385 - $40,740
485 Added 0.84%
58,351 $4.89 Million
Q2 2024

Jul 08, 2024

SELL
$67.33 - $77.71 $32,655 - $37,689
-485 Reduced 0.83%
57,866 $4.46 Million
Q1 2024

May 16, 2024

SELL
$57.6 - $68.62 $7,200 - $8,577
-125 Reduced 0.21%
58,351 $4 Million
Q4 2023

Feb 02, 2024

SELL
$48.64 - $57.81 $68,096 - $80,934
-1,400 Reduced 2.34%
58,476 $3.38 Million
Q3 2023

Oct 30, 2023

SELL
$50.19 - $54.68 $22,585 - $24,606
-450 Reduced 0.75%
59,876 $3.16 Million
Q2 2023

Aug 15, 2023

SELL
$49.72 - $54.64 $29,832 - $32,784
-600 Reduced 0.98%
60,326 $3.26 Million
Q1 2023

May 04, 2023

SELL
$45.09 - $50.03 $21,553 - $23,914
-478 Reduced 0.78%
60,926 $3.05 Million
Q4 2022

Jan 18, 2023

SELL
$39.56 - $47.22 $30,065 - $35,887
-760 Reduced 1.22%
61,404 $0
Q3 2022

Oct 24, 2022

SELL
$36.71 - $109.66 $3,303 - $9,869
-90 Reduced 0.14%
62,164 $2.52 Million
Q1 2022

Apr 26, 2022

SELL
$40.9 - $45.1 $21,268 - $23,452
-520 Reduced 0.83%
62,254 $2.73 Million
Q4 2021

Feb 04, 2022

BUY
$38.07 - $44.87 $42,828 - $50,478
1,125 Added 1.82%
62,774 $2.67 Million
Q3 2021

Oct 28, 2021

BUY
$41.23 - $45.88 $11,544 - $12,846
280 Added 0.46%
61,649 $2.68 Million
Q2 2021

Aug 06, 2021

SELL
$38.58 - $44.24 $10,416 - $11,944
-270 Reduced 0.44%
61,369 $2.62 Million
Q1 2021

May 12, 2021

SELL
$35.27 - $39.67 $19,398 - $21,818
-550 Reduced 0.88%
61,639 $2.38 Million
Q4 2020

Feb 01, 2021

BUY
$33.15 - $41.97 $21,547 - $27,280
650 Added 1.06%
62,189 $2.24 Million
Q3 2020

Nov 03, 2020

SELL
$34.44 - $42.23 $10,332 - $12,668
-300 Reduced 0.49%
61,539 $2.35 Million
Q2 2020

Aug 13, 2020

SELL
$30.19 - $39.11 $188,989 - $244,828
-6,260 Reduced 9.19%
61,839 $2.17 Million
Q1 2020

May 12, 2020

BUY
$25.83 - $45.71 $52,176 - $92,334
2,020 Added 3.06%
68,099 $2.22 Million
Q4 2019

Mar 04, 2020

BUY
$37.87 - $45.37 $2.5 Million - $3 Million
66,079 New
66,079 $2.99 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $125B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Tandem Capital Management Corp Portfolio

Follow Tandem Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tandem Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Tandem Capital Management Corp with notifications on news.